Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma

World Journal of Gastroenterology

Volumn 22, Issue 13, 2016, Pages 3592-3601

  Engin, Atilla ^a   Gonul, Ipek Isik ^a   Engin, Ayse Basak ^a   Karamercan, Ahmet ^a   Dincel, Aylin Sepici ^a   Dursun, Ayse ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Colorectal carcinoma; Indoleamine 2,3 dioxygen; Lymph node metastasis; Lymphovascular invasion; Tryptophan

Indexed keywords

BIOPTERIN; CREATININE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; TRYPTOPHAN; TUMOR MARKER;

ADULT; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; BLOOD; CARCINOMA; CASE CONTROL STUDY; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; LYMPHATIC SYSTEM; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SECONDARY; TUMOR INVASION; URINALYSIS; URINE;

BIOMARKERS, TUMOR; BIOPTERIN; CARCINOMA; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPTERIN; PREDICTIVE VALUE OF TESTS; TRYPTOPHAN; URINALYSIS;

EID: 84962732100     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i13.3592     Document Type: Article

References (40)

1. Tatar M, Tatar F. Colorectal cancer in Turkey: current situation and challenges for the future. Eur J Health Econ 2010; 10 Suppl 1: S99-105 [PMID: 20012668 DOI: 10.1007/s10198-009-0197-7]
2. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88: 1739-1757 [PMID: 10738234]
3. Cianchi F, Messerini L, Palomba A, Boddi V, Perigli G, Pucciani F, Bechi P, Cortesini C. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 1997; 40: 1170-1175; discussion 1175-1176 [PMID: 9336111]
4. Yamamoto S, Watanabe M, Hasegawa H, Baba H, Yoshinare K, Shiraishi J, Kitajima M. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology 2004; 51: 998-1000 [PMID: 15239233]
5. Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y, Shimoda T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 92-100 [PMID: 15690664]
6. Cho YB, Chun HK, Yun HR, Kim HC, Yun SH, Lee WY. Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepatogastroenterology 2009; 56: 1335-1340 [PMID: 19950787]
7. Kronberg U, López-Kostner F, Soto G, Zúñiga A, Wistuba I, Miranda V, Pinto E, Viviani P, Marshall G. Detection of lymphatic micrometastases in patients with stages I and II colorectal cancer: impact on five-year survival. Dis Colon Rectum 2004; 47: 1151-1157 [PMID: 15164250]
8. Messerini L, Cianchi F, Cortesini C, Comin CE. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol 2006; 37: 1259-1267 [PMID: 16949928 DOI: 10.1016/j.humpath.2006.04.023]
9. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71 [PMID: 12513963]
10. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998; 83: 666-672 [PMID: 9708929]
11. Wasif N, Faries MB, Saha S, Turner RR, Wiese D, McCarter MD, Shen P, Stojadinovic A, Bilchik AJ. Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery 2010; 147: 352-357 [PMID: 20116081 DOI: 10.1016/j.surg.2009.10.008]
12. Adell G, Boeryd B, Franlund B, Sjödahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996; 162: 637-642 [PMID: 8891622]
13. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002; 45: 750-755; discussion 755-756 [PMID: 12072625]
14. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964 [PMID: 17008531 DOI: 10.1126/science.1129139]
15. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, Werner ER, Werner-Felmayer G, Weiss HG, Göbel G, Margreiter R, Königsrainer A, Fuchs D, Amberger A. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006; 12: 1144-1151 [PMID: 16489067 DOI: 10.1158/1078-0432. CCR-05-1966]
16. Murr C, Bergant A, Widschwendter M, Heim K, Schröcksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem 1999; 45: 1998-2004 [PMID: 10545071]
17. Schoedon G, Troppmair J, Adolf G, Huber C, Niederwieser A. Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res 1986; 6: 697-703 [PMID: 3106526]
18. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y. Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 1992; 111: 65-72 [PMID: 1402999 DOI: 10.1016/0022-510X(92)90113-Y]
19. Widner B, Weiss G, Fuchs D. Tryptophan degradation to control T-cell responsiveness. Immunol Today 2000; 21: 250 [PMID: 10782059 DOI: 10.1016/S0167-5699(00)01616-9]
20. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 2002; 86: 1691-1696 [PMID: 12087451 DOI: 10.1038/sj.bjc.6600336]
21. Rose DP. Tryptophan metabolism in carcinoma of the breast. Lancet 1967; 1: 239-241 [PMID: 4163145 DOI: 10.1016/S0140-6736(67)92303-3]
22. Zamanakou M, Germenis AE, Karanikas V. Tumor immune escape mediated by indoleamine 2,3-dioxygenase. Immunol Lett 2007; 111: 69-75 [PMID: 17644189 DOI: 10.1016/j.imlet.2007.06.001]
23. Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 2005; 11: 312-319 [PMID: 15711557 DOI: 10.1038/nm1196]
24. Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003; 9: 1269-1274 [PMID: 14502282 DOI: 10.1038/nm934]
25. Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20: 469-473 [PMID: 10500295 DOI: 10.1016/S0167-5699(99)01520-0]
26. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 2005; 97: 219-225 [PMID: 15687365 DOI: 10.1093/jnci/dji020]
27. Lindboe CF. Lymph node harvest in colorectal adenocarcinoma specimens: The impact of improved fixation and examination procedures. APMIS 2011; 119: 347-355 [PMID: 21569092 DOI: 10.1111/j.1600-0463.2011.02748.x]
28. Hitchcock CL, Sampsel J, Young DC, Martin EW, Arnold MW. Limitations with light microscopy in the detection of colorectal cancer cells. Dis Colon Rectum 1999; 42: 1046-1052 [PMID: 10458129]
29. Gastl G, Spizzo G, Obrist P, Dünser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 2000; 356: 1981-1982 [PMID: 11130529]
30. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 1997; 43: 2424-2426 [PMID: 9439467]
31. Engin AB, Ergun MA, Yurtcu E, Kan D, Sahin G. Effect of ionizing radiation on the pteridine metabolic pathway and evaluation of its cytotoxicity in exposed hospital staff. Mutat Res 2005; 585: 184-192 [PMID: 15998597 DOI: 10.1016/j.mrgentox.2005.05.005]
32. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G. Neopterin, Biochemistry, Methods, Clinical Application. Berlin: Walter de Gruyter, 1992
33. Liu X, Newton RC, Friedman SM, Scherle PA. Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. Curr Cancer Drug Targets 2009; 9: 938-952 [PMID: 20025603 DOI: 10.2174/156800909790192374]
34. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 1989; 262: 861-866 [PMID: 2511835]
35. Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 82-90 [PMID: 16139256 DOI: 10.1016/j.cca.2005.06.013]
36. Van den Eynde B. [A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase]. Bull Mem Acad R Med Belg 2003; 158: 356-363; discussion 364-365 [PMID: 15132006]
37. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002; 196: 459-468 [PMID: 12186838 DOI: 10.1084/jem.20020121]
38. Xu H, Zhang GX, Ciric B, Rostami A. IDO: A double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett 2008; 121: 1-6 [PMID: 18824197 DOI: 10.1016/j.imlet.2008.08.008]
39. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-2666 [PMID: 16371631 DOI: 10.1056/NEJMoa051424]
40. Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 2010; 14: 1074-1080 [PMID: 20431977 DOI: 10.1007/s11605-010-1206-y]